Insider Stock Buying Reaches US$527.5k On Avid Bioservices
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase stock, like in Avid Bioservices, Inc.'s (NASDAQ:CDMO) instance, it's good news for sha
Those Who Invested in Avid Bioservices (NASDAQ:CDMO) Five Years Ago Are up 104%
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersAutonomix Medical (NASDAQ:AMIX) shares moved upwards by 11.1% to $1.3 during Tuesday's after-market session. The company's market cap stands at $24.4 million. Unicycive Therapeutics (NASDAQ:UNC
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating
Craig-Hallum analyst Matt Hewitt maintains $Avid Bioservices(CDMO.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 43.9% and a total average return of -3.8% over th
Vetter Announces Plans to Expand Its Capacity in the U.S. and Germany
Leading globally operating CDMO outlines location and design of new manufacturing sites to meet increasing customer demands Vetter Advisory Board decides on strategic path forward for further independ
BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform From CelluTx
ADELAIDE, South Australia, June 3, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced the exclusive rights to u
Vetter Wins Best Managed Companies Award 2024
Jury of the renowned business award recognizes CDMO as Best in Class Vetter defends Gold and Best in Class status CDMO impresses in all four evaluation categories Outstanding example for combining e
Avid Bioservices Earns Committed Badge From EcoVadis for Sustainability Performance
Avid earned a score of 56 from EcoVadis, placing the company in the 62nd percentile globally.
Craig-Hallum Sticks to Their Buy Rating for Avid Bioservices (CDMO)
Avid Bioservices to Participate at Upcoming Investor Conferences
TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high
Avid Bioservices Currently Up 11 Consecutive Days, on Track for Longest Winning Streak on Record -- Data Talk
Avid Bioservices, Inc. (CDMO) is currently at $8.37, up $0.12 or 1.45% --Would be highest close since March 6, 2024, when it closed at $8.79 --Currently up 11 consecutive days; up 30.99% over this p
How Novo-Catalent Deal Affects Halozyme (HALO)?
Avid Bioservices Is Maintained at Outperform by RBC Capital
Avid Bioservices Is Maintained at Outperform by RBC Capital
Express News | RBC Capital Maintains Outperform on Avid Bioservices, Raises Price Target to $8
Avid Bioservices Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/30/2024 11.42% RBC Capital $7 → $8 Maintains Outperform 03/11/2024 67.13% Stephens & Co. $15 → $12 Main
Analysts' Opinions Are Mixed on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Decibel Cannabis Company (OtherDBCCF) and Avid Bioservices (CDMO)
Q3 2024 Avid Bioservices Inc Earnings Call
Analysts Offer Insights on Healthcare Companies: AIM ImmunoTech (AIM) and Avid Bioservices (CDMO)
Express News | Avid Bioservices Inc : RBC Raises Target Price to $8 From $7
Earnings Call Summary | Avid Bioservices(CDMO.US) Q3 2024 Earnings Conference
The following is a summary of the Avid Bioservices, Inc. (CDMO) Q3 2024 Earnings Call Transcript:Financial Performance:Avid Bioservices saw a significant increase in revenues by over 30% in Q3 2024 co
No Data